AIF Capital is pleased to announce the investment of US$14.5 million by AIF Capital Fund IV in Waston Medical Co., Ltd. (“Waston”), a leading manufacturer of orthopedic implants and surgical staplers in China.
Based in Changzhou in Jiangsu, Waston is China’s largest independently owned manufacturer of orthopedic implants and surgical staplers with an extensive domestic sales network covering Class I to III hospitals in most provinces in China. The company also exports to South America, Southeast Asia and Europe.
AIF Capital’s investment will go towards further expansion of existing production capacity and distribution channel, M&A opportunities, as well as addition of new product lines.
About AIF Capital
AIF Capital (www.aifcapital.com) is one of Asia’s long-standing independent private equity firms and is focused on mid-market growth opportunities in emerging Asia. The Firm has an established track record of over two decades in implementing a pan-regional strategy of identifying and growing companies as well as steering them through multiple major economic cycles.
Since its inception in 1994, AIF Capital has received investor commitments in excess of US$2.0 billion and provided capital for expansion and buy-outs through 42 investments in ten Asian countries. Its team of 22 investment professionals across its offices in Hong Kong, Beijing, New Delhi and Singapore oversees a diversified pan-Asian portfolio of investments across various sectors. These include healthcare & pharmaceuticals, supply chain management, equipment leasing & logistics, consumer, financial services and industrial manufacturing.
Limited partners in AIF Capital-managed funds include major corporate and government pension and investment funds, insurance companies, financial institutions, as well as multilateral agencies and family offices from North America, Australia, Asia, the Middle East and Europe.
For further questions, please contact Peter Amour or Doris Ng at +852-2912-7888 or email inquiries to email@example.com